Evidence map›Paper›PMID 40448827›Full record

ReviewEuropean journal of pediatrics2025

Congenital CMV infection and central nervous system involvement: mechanisms, treatment, and long-term outcomes.

Matteo Palmetti, Elisabetta Venturini, Luca Bartolini, Elena Chiappini, Hermione Lyall, Luisa Galli

Abstract readReview
PubMed Publisher
In one paragraph

Review in European journal of pediatrics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. The Placenta as an Immunological Environment.British journal of biomedical science · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Matteo PalmettiDepartment of Health Sciences, Postgraduate School of Pediatrics, University of Florence, Florence, Italy.
Elisabetta VenturiniPediatric Infectious Diseases Unit, Meyer Children's Hospital IRCCS, Florence, Italy. elisabetta.venturini@meyer.it.ORCID http://orcid.org/0000-0002-0048-3933
Luca BartoliniNeuroscience Department, Meyer Children's Hospital IRCCS, Florence, Italy.ORCID http://orcid.org/0000-0003-2755-8218
Elena ChiappiniPediatric Infectious Diseases Unit, Meyer Children's Hospital IRCCS, Florence, Italy.ORCID http://orcid.org/0000-0002-1476-4752
Hermione LyallImperial College Healthcare NHS Trust, London, UK.ORCID http://orcid.org/0000-0002-1255-1833
Luisa GalliPediatric Infectious Diseases Unit, Meyer Children's Hospital IRCCS, Florence, Italy.ORCID http://orcid.org/0000-0002-7912-3366

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Congenital Cytomegalovirus (cCMV) infection is the leading infectious cause of non-genetic sensorineural hearing loss and a significant cause of neurodevelopmental disability in infants. This narrative review aims to describe the mechanisms by which CMV disrupts fetal brain development in early gestation, the importance of neonatal neuroimaging in predicting prognosis, and the optimal intervention for preventing neurologic sequelae. We performed a literature search on PUBMED on this topic and selected the most relevant results, including studies describing neurologic outcomes, neuroimaging, hearing loss, treatment efficacy, or follow-up recommendations in infants with cCMV, prioritizing randomized controlled trials (RCTs), systematic reviews, and expert consensus guidelines. The pathogenesis of cCMV infection is the result of various mechanisms that the virus uses to replicate in the developing fetal central nervous system; the major cause of structural damage to the brain is aberrant migration of neuronal precursors. Recent literature stresses the importance of neuroimaging and the role of neuroradiologic scores to predict neurologic sequelae. The management of infants with isolated SNHL, especially those diagnosed after the neonatal period, remains controversial, though emerging evidence suggests a potential therapeutic window up to 12 weeks of age. Follow-up protocols should be tailored based on clinical presentation, with close audiologic and developmental surveillance.

conclusionsDespite recent advances, key knowledge gaps persist regarding the mechanisms of CNS injury, optimal screening for vestibular dysfunction, neonatal biomarkers of prognosis, and treatment indications for isolated SNHL. Targeted research and standardized follow-up models are essential to improve outcomes in this vulnerable population. WHAT IS KNOWN: • Congenital Cytomegalovirus infection is the leading infectious cause of non-genetic sensorineural hearing loss and a significant cause of neurodevelopmental disability in infants. • Neurological complications remain the most significant contributors to morbidity in cCMV infection. WHAT IS NEW: • Beyond classical neurological manifestations, cCMV infected babies show a high prevalence of vestibular dysfunction; neurodevelopmental sequelae are frequent, including autism, attention deficit, and learning difficulties, and may occur even in asymptomatic cases. Neuroradiologic scoring systems proved to be predictive of developmental outcomes. • This review proposes a structured follow-up model tailored to clinical and imaging findings and discusses prognostic factors that may help identify children at increased risk for late-onset sequelae.

Indexed as

Cytomegalovirus InfectionsHearing Loss, SensorineuralHumansInfantInfant, NewbornNeurodevelopmental DisordersNeuroimagingPrognosisCongenital CytomegalovirusDevelopmental disabilitiesNeuroimagingPreventionVestibular dysfunctionWhite matter disease

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.